SPI1 and agammaglobulinemia: This case highlights the diagnostic value of whole-exome sequencing (WES) in agammaglobulinemia cases of unknown etiology following negative panel results, while also prompting the critical need for commercial assays to undergo regular updates to incorporate newly validated genes like SPI1.